Kommalapati, A., Laliotis, G., Glover, M., Selig, G., Kollipara, R., Mahmood, T., … Tan, A. (2023). Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Kommalapati, Ajitha, George Laliotis, Michael Glover, Grayce Selig, Revathi Kollipara, Tamara Mahmood, Sumit Shah, et al. “Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Kommalapati A, Laliotis G, Glover M, Selig G, Kollipara R, Mahmood T, et al. Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Kommalapati, Ajitha, et al. “Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Kommalapati A, Laliotis G, Glover M, Selig G, Kollipara R, Mahmood T, Shah S, Hoimes CJ, Stewart TF, Sharma S, Malhotra M, Pajak N, Calhoun M, ElNaggar A, Liu MC, Basu A, Galsky MD, Tan A. Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis. JOURNAL OF CLINICAL ONCOLOGY. 2023.